Back
Cue Biopharma Vs. FibroGen Industry Stock Comparison
Sell
28
CUE
Cue Biopharma
Last Price:
1.10
Seasonality Move:
14.02%
Buy
54
FGEN
FibroGen
Last Price:
0.38
Seasonality Move:
50.95%
Sell
28
Cue Biopharma (CUE)
is a Sell
Is Cue Biopharma a Buy, Sell or Hold?
- The current Cue Biopharma [CUE] share price is $1.09. The Score for CUE is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
- CUE is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
54
FibroGen (FGEN)
is a Buy
Is FibroGen a Buy, Sell or Hold?
- The current FibroGen [FGEN] share price is $0.39. The Score for FGEN is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
- FGEN is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
CUE Stock Price Chart
What is Cue Biopharma's stock price today?
-
The Cue Biopharma share price today is $1.09
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CUE is experiencing slight buying pressure.
FGEN Stock Price Chart
CUE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.08 | Sell |
| Relative Strength Index (14 RSI): | 40.82 | Sell |
| Chaikin Money Flow: | 0 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.18 - 1.74) | Sell |
| Bollinger Bands (100): | (0.57 - 1.35) | Buy |
FGEN Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.01 | Buy |
| Relative Strength Index (14 RSI): | 57.4 | Buy |
| Chaikin Money Flow: | -41389 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.31 - 0.37) | Buy |
| Bollinger Bands (100): | (0.23 - 0.77) | Sell |
CUE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.09 | Buy |
| 20-day SMA: | 1.42 | Sell |
| 50-day SMA: | 1.2 | Sell |
| 200-day SMA: | 1.36 | Sell |
| 8-day EMA: | 1.15 | Sell |
| 20-day EMA: | 1.29 | Sell |
| 50-day EMA: | 1.23 | Sell |
| 200-day EMA: | 1.44 | Sell |
FGEN Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.37 | Buy |
| 20-day SMA: | 0.34 | Buy |
| 50-day SMA: | 0.36 | Buy |
| 200-day SMA: | 1 | Sell |
| 8-day EMA: | 0.37 | Buy |
| 20-day EMA: | 0.36 | Buy |
| 50-day EMA: | 0.38 | Buy |
| 200-day EMA: | 1.2 | Sell |
Cue Biopharma Earnings Growth & CUE Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.40 per share, and an increase next year of $0.19 per share.
FibroGen Earnings Growth & FGEN Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.29 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.70 per share, and an increase next year of $0.48 per share.
Cue Biopharma Technical Analysis
| Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | Nov 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | 25 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
FibroGen Technical Analysis
| Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | Nov 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | 25 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||